Treatments

Diaphoresis symptoms, Causes, Treatment, Prevention

Diaphoresis Symptoms, Causes, Treatment

Read all about Diaphoresis symptoms, Causes , Treatment, Prevention. Everyone sweats. Your body sweats to chill you off when you are overheated. In any case, there is a point that sweating is no more helpful, rather harmful. Have you ever found yourself so damp with sweat that you were drenched and soaked ...

Read More »

How Long Xanax Withdrawal Symptoms Last

How Long Xanax Withdrawal Symptoms Last

Learn what are Xanax Withdrawal Symptoms, how long Xanax withdrawal symptoms last and why first few hour of quiting Xanax (alprazolam) should be critical monitored by the physician. Xanax (alprazolam) is a benzodiazepine class of drugs that reduce the over-activity in the brain and central nervous system by mounting the ...

Read More »

Darzalex/Daratumumab Side effects, Cost, Dosage for Multiple Myeloma

Darzalex side effects, cost, dosage for multiple myeloma

Darzalex/daratumumab side effects, cost, dosage for multiple myeloma. Darzalex is marketed by Janssen Biotech of Horsham, Pennsylvania. FDA approved new drug Darzalex for patients suffering from multiple myeloma on November 16, 2015. Daratumumab is active ingredient of this drug. FDA indicated this drug for treatment of patients with multiple myeloma who have received ...

Read More »

Tagrisso/osimertinib side effects, cost, dosage for lung cancer

Tagrisso/osimertinib side effects, cost, dosage for lung cancer

Tagrisso/osimertinib side effects, cost, dosage for lung cancer.Tagrisso is marketed by Astra Zeneca Pharmaceuticals based in Wilmington, Delaware. FDA approves new pill Tagrisso/osimertinib to treat certain patients with non-small cell lung cancer on November 13, 2015. FDA has approved Tagrisso (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic ...

Read More »

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma

Nucala/Mepolizumab Side effects, Cost, Dosage for Asthma. Nucala is marketed by GSK. Nucala mepolizumab is approved by FDA on 4th November 2015.Nucala mepolizumab is an interleukin-5 adversary monoclonal antibody (IgG1 kappa) demonstrated for the extra support or add-on treatment of patients with serious eosinophilic asthma. Nucala is a physician recommended ...

Read More »

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma

Yondelis/Trabectedin Side effects, Cost, Dosage for Leiomyosarcoma and Liposarcoma.Yondelis is marketed by Janssen Products of Raritan, New Jersey. yondelis for Leiomyosarcoma and Liposarcoma. Yondelis/trabectedin is first approved by FDA on 23rd October 2015.Yondelis trabectedin is chemotherapy for the treatment of particular type of soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – ...

Read More »

Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia

Strensiq-Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia

Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia. Strensiq is marketed by Alexion pharmaceuticals. Strensiq is approved by FDA on 23rd October 2015.Its active ingredient is asfotase alfa.Strensiq asfotase alfa is used as the initially endorsed treatment for perinatal, infantile and juvenile onset hypophosphatasia (HPP). HPP is an uncommon, hereditary, progressive, ...

Read More »

Genvoya side effects, cost, dosage for HIV Treatment

Genvoya side effects, cost, dosage for HIV Treatment

The population of HIV patient has grown; there is an increased risk for development of treatment-related co morbidities, including low bone mineral density and renal mutilation. But now the world have a solution against such a terrible problem termed as HIV in the form of Genvoya, which has developed from ...

Read More »

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma

Imlygic/Talimogene Laherparepvec Side effects, Cost, Dosage for Melanoma, FDA approval, Mechanism, Clinical trials. Imlygic is marketed by BioVex Inc., a subsidiary of Amgen Inc. The U.S. Food and Drug Administration approved Imlygic (talimogene laherparepvec) on 27th October 2015, the first FDA-approved oncolytic virus therapy, for the treatment of melanoma lesions in the ...

Read More »